These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1436404

  • 21. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.
    Fuxe K, O'Connor WT, Antonelli T, Osborne PG, Tanganelli S, Agnati LF, Ungerstedt U.
    Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5591-5. PubMed ID: 1535159
    [Abstract] [Full Text] [Related]

  • 22. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine.
    Benwell ME, Balfour DJ, Lucchi HM.
    Psychopharmacology (Berl); 1993 Jun 15; 112(4):467-74. PubMed ID: 7871059
    [Abstract] [Full Text] [Related]

  • 23. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A, Baranyi M, Windisch K, Petkova-Kirova P, Gagov H, Kalfin R.
    Brain Res Bull; 2017 Sep 15; 134():246-252. PubMed ID: 28802898
    [Abstract] [Full Text] [Related]

  • 24. Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism.
    Invernizzi R, Pozzi L, Garattini S, Samanin R.
    Neuropharmacology; 1992 Mar 15; 31(3):221-7. PubMed ID: 1630590
    [Abstract] [Full Text] [Related]

  • 25. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
    Abekawa T, Ohmori T, Koyama T.
    Brain Res; 1994 Apr 18; 643(1-2):276-81. PubMed ID: 7518327
    [Abstract] [Full Text] [Related]

  • 26. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
    Laitinen K, Crawley JN, Mefford IN, De Witte P.
    Brain Res; 1990 Jul 23; 523(2):342-6. PubMed ID: 1698106
    [Abstract] [Full Text] [Related]

  • 27. Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens.
    Pierce RC, Duffy P, Kalivas PW.
    Synapse; 1995 May 23; 20(1):33-6. PubMed ID: 7624827
    [Abstract] [Full Text] [Related]

  • 28. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE, Sorg BA, Chapman MA, Kalivas PW.
    Neuropharmacology; 1991 Dec 23; 30(12A):1269-74. PubMed ID: 1686300
    [Abstract] [Full Text] [Related]

  • 29. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats.
    Invernizzi R, Pozzi L, Samanin R.
    Neuropharmacology; 1991 Jun 23; 30(6):575-8. PubMed ID: 1922681
    [Abstract] [Full Text] [Related]

  • 30. Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens: a microdialysis study.
    Zetterström T, Fillenz M.
    Neuropharmacology; 1990 Feb 23; 29(2):129-34. PubMed ID: 2109839
    [Abstract] [Full Text] [Related]

  • 31. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.
    Blaha CD, Coury A, Fibiger HC, Phillips AG.
    Neuroscience; 1990 Feb 23; 34(3):699-705. PubMed ID: 2352647
    [Abstract] [Full Text] [Related]

  • 32. Extracellular dopamine and its metabolites in the nucleus accumbens of Fischer and Lewis rats: basal levels and cocaine-induced changes.
    Strecker RE, Eberle WF, Ashby CR.
    Life Sci; 1995 Feb 23; 56(6):PL135-41. PubMed ID: 7530315
    [Abstract] [Full Text] [Related]

  • 33. A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study.
    Ferraro L, Frankowska M, Marcellino D, Zaniewska M, Beggiato S, Filip M, Tomasini MC, Antonelli T, Tanganelli S, Fuxe K.
    Neuropsychopharmacology; 2012 Jul 23; 37(8):1856-66. PubMed ID: 22453136
    [Abstract] [Full Text] [Related]

  • 34. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ, Taylor DA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May 23; 355(5):582-8. PubMed ID: 9151296
    [Abstract] [Full Text] [Related]

  • 35. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
    Karoum F, Suddath RL, Wyatt RJ.
    Eur J Pharmacol; 1990 Sep 04; 186(1):1-8. PubMed ID: 2282931
    [Abstract] [Full Text] [Related]

  • 36. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis.
    Hernandez L, Auerbach S, Hoebel BG.
    Life Sci; 1988 Sep 04; 42(18):1713-23. PubMed ID: 2452334
    [Abstract] [Full Text] [Related]

  • 37. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
    Bean AJ, Adrian TE, Modlin IM, Roth RH.
    J Pharmacol Exp Ther; 1989 Jun 04; 249(3):681-7. PubMed ID: 2732943
    [Abstract] [Full Text] [Related]

  • 38. Monoamine metabolism in the striatum of the rat brain during drug infusion into the nucleus accumbens.
    Saul'skaya NB.
    Neurosci Behav Physiol; 1997 Jun 04; 27(6):728-33. PubMed ID: 9406229
    [Abstract] [Full Text] [Related]

  • 39. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.
    Tanganelli S, O'Connor WT, Ferraro L, Bianchi C, Beani L, Ungerstedt U, Fuxe K.
    Neuroscience; 1994 Jun 04; 60(3):649-57. PubMed ID: 7936192
    [Abstract] [Full Text] [Related]

  • 40. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM, Zubieta JK, Rezvani AH, Cubeddu LX.
    J Pharmacol Exp Ther; 1990 Feb 04; 252(2):817-25. PubMed ID: 2138224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.